Nexpoint Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Nexpoint Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,464,807	Closed	-$21.9M	–	148
2022 Q4	$21.9M	Buy	+1,464,807	New	+$20.3M	1.7%	19

Nexpoint Asset Management's AVEO Position: Q1 2023 in Review

Nexpoint Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,464,807 shares — an estimated $21.9M sold.

Nexpoint Asset Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $21.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Nexpoint Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Nexpoint Asset Management sold 1,464,807 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $21.9M.
Nexpoint Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Nexpoint Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $21.9M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Nexpoint Asset Management's 13F filing for Q1 2023, filed 15 May 2023.